Treatment review.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000328:Adult; D002100:Cachexia / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D017245:Foscarnet / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D012514:Sarcoma, Kaposi / Q000098:blood supply / Q000188:drug therapy*; D013281:Stomatitis, Aphthous / Q000188:drug therapy; D013739:Testosterone / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use*
D007376:Interleukin-2; D005473:Fluoxetine; D017245:Foscarnet; D013739:Testosterone; D013792:Thalidomide